West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 126,400 | 117,800 | 100,500 | 104,100 | 106,500 |
| Cost of Goods | 85,000 | 81,400 | 70,700 | 77,800 | 75,800 |
| Gross Profit | 41,400 | 36,400 | 29,800 | 26,300 | 30,700 |
| Operating Expenses | 30,600 | 30,300 | 8,600 | 29,400 | 21,700 |
| Operating Income | 10,800 | 6,500 | 21,900 | -2,300 | 9,800 |
| Interest Expense | 1,700 | 1,900 | 3,600 | 2,100 | 2,500 |
| Other Income | 700 | 500 | 900 | -400 | 100 |
| Pre-tax Income | 9,800 | 5,100 | 19,200 | -4,800 | 7,400 |
| Income Tax | 2,900 | 1,300 | 6,100 | -2,800 | 2,200 |
| Net Income Continuous | 6,900 | 3,800 | 13,100 | -2,000 | 5,200 |
| Net Income Discontinuous | N/A | N/A | -9,700 | 5,600 | 100 |
| Net Income | $6,900 | $3,800 | $3,400 | $3,600 | $5,300 |
| EPS Basic Total Ops | 0.12 | 0.07 | 0.06 | 0.06 | 0.09 |
| EPS Basic Continuous Ops | 0.12 | 0.07 | 0.23 | -0.04 | 0.09 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.17 | 0.10 | 0.00 |
| EPS Diluted Total Ops | 0.12 | 0.07 | 0.06 | 0.06 | 0.09 |
| EPS Diluted Continuous Ops | 0.12 | 0.07 | 0.23 | -0.04 | 0.09 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.17 | 0.10 | 0.00 |
| EBITDA(a) | $19,300 | $14,600 | $28,700 | $5,900 | $18,100 |